COMMUNIQUÉS West-GlobeNewswire

Vical to Discontinue Clinical Development of VL-2397 as it Considers Near Term Strategic Alternatives

19/02/2019 - 23:45

SAN DIEGO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that it has decided to discontinue the Phase 2 clinical trial of VL‑2397 that was initiated in the first quarter of 2018. The [...]

2019 Budget Focuses on Savings for Individuals and Families

19/02/2019 - 23:39

VICTORIA, British Columbia, Feb. 19, 2019 (GLOBE NEWSWIRE) -- The budget presented today by the B.C. government is strongly focused on reducing costs for B.C. families, a move which will be welcomed individually by [...]

REVA Announces Voluntary Suspension of Trading

19/02/2019 - 23:36

SAN DIEGO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 20 February 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating [...]

Nashville Business Leader Acquires Integrative Life Center

19/02/2019 - 23:34

Former Premier Parking CEO, Ryan Chapman, plans to broaden services of Nashville-based behavioral health care provider NASHVILLE, Tenn., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Ryan Chapman, who grew and sold a nationwide [...]

Sienna Senior Living Inc. Reports 2018 Fourth Quarter Financial Results

19/02/2019 - 23:08

MARKHAM, Ontario, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three months and year ended December 31, 2018. The [...]

Lifeline Biotechnologies, Inc. Updates Current Shareholders and the Public

19/02/2019 - 23:02

Reno, Nevada, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- We are pleased to share current information and developments with our stakeholders and the public, February 19, 2019. Regarding Lifeline’s investment [...]

SeaSpine Appoints Kim Commins-Tzoumakas and Renee Gaeta to its Board of Directors

19/02/2019 - 23:00

CARLSBAD, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]

Digirad Corporation to Release 2018 Fourth Quarter Financial Results on March 1, 2019

19/02/2019 - 23:00

SUWANEE, Ga., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD) will release financial results for its fourth quarter ended December 31, 2018 before the market opens on Friday, March 1, 2019. A [...]

Oxford Immunotec Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for March 11, 2019

19/02/2019 - 22:45

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it plans to [...]

Spring Bank Pharmaceuticals Appoints Atif Abbas, M.D., as Vice President, Head of Oncology & Immunology Clinical Development

19/02/2019 - 22:38

HOPKINTON, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]

MannKind Corporation to Hold 2018 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2019

19/02/2019 - 22:31

WESTLAKE VILLAGE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2018 fourth quarter and full year financial results on Tuesday, February 26, 2019 and its management will [...]

BeiGene Initiates Global Phase 2 Trial of Zanubrutinib in Patients with Relapsed or Refractory Marginal Zone Lymphoma

19/02/2019 - 22:30

CAMBRIDGE, Mass. and BEIJING, China, Feb. 19, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Molecular Templates Appoints Roger J. Waltzman, M.D., as Chief Medical Officer

19/02/2019 - 22:30

AUSTIN, Texas, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary engineered toxin bodies [...]

Amedisys Signs Definitive Agreement to Acquire RoseRock Healthcare

19/02/2019 - 22:30

Acquisition Marks Company’s First Hospice Venture in Oklahoma BATON ROUGE, La., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care [...]

Tonix Pharmaceuticals Announces New Board Member, James Treco

19/02/2019 - 22:30

NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) today announced the appointment of James Treco to its Board of Directors, effective immediately. Mr. [...]

Dova Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on March 5, 2019

19/02/2019 - 22:15

DURHAM, N.C., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) will host a conference call on Tuesday, March 5, 2019 at 9:00 a.m. ET to discuss fourth quarter and full year 2018 financial [...]

Neuronetics to Report Fourth Quarter and Fiscal Year 2018 Financial and Operating Results and Host Conference Call

19/02/2019 - 22:15

MALVERN, Pa., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]

Sienna Biopharmaceuticals Announces Proposed Public Offering of Common Stock

19/02/2019 - 22:10

WESTLAKE VILLAGE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that it has commenced a proposed underwritten public [...]

Principia Biopharma Appoints John W. Smither to Board of Directors

19/02/2019 - 22:10

SOUTH SAN FRANCISCO, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]